CC
CLOV icon

Casdin Capital’s Clover Health Investments CLOV Stock Holding History

Casdin Capital’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-726,511
Closed -$9.68M – 55
2021
Q2 		$9.68M Hold
726,511
– – 0.25% 44
2021
Q1 		$5.49M Buy
+726,511
New +$8.2M 0.16% 44

Other funds holding CLOV

GCP
Greenoaks Capital Partners Orinda, California $2.3B AUM 19.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Casdin Capital's CLOV Position: Q3 2021 in Review

Casdin Capital sold out of Clover Health Investments (CLOV) in Q3 2021, closing a stake of 726,511 shares — an estimated $9.68M sold.

Casdin Capital first reported a position in CLOV in Q1 2021 and held it in 2 quarters. The position peaked at $9.68M in Q2 2021. 149 funds tracked by Wall St. Rank hold CLOV as of Q3 2021.

  • Casdin Capital reported no remaining Clover Health Investments position as of Q3 2021 after selling out during the quarter.
  • Casdin Capital sold 726,511 Clover Health Investments shares in Q3 2021, an estimated $9.68M.
  • Casdin Capital first reported a position in Clover Health Investments in Q1 2021 and held it in 2 quarters.
  • Casdin Capital's Clover Health Investments position peaked at $9.68M in Q2 2021.
  • 149 funds tracked by Wall St. Rank held Clover Health Investments as of Q3 2021.

Based on Casdin Capital's 13F filing for Q3 2021, filed 15 Nov 2021.